305709
Prevalence and Incidence of Psychiatric Disorder Treated Episodes in an Occupational Cohort: Sociodemographic and Work Trends across a 6 Year Period
Methods: In this historical cohort study, yearly prevalence and incidence rates of any DSM-IV-TR treated psychiatric disorder episode of care were calculated for the years 2005 through 2010. Differences in rates by subgroups were assessed using chi-square tests of significant associations at a significance level of P≤ .05.
Results: The sample size ranged from 18,744 in 2005 to 25,922 in 2010. The 12-month prevalence ranged from 3.6% in 2008 to 4.3% in 2009. During 2006-2010, the 12-month incidence ranged from 3.2% in 2008 to 3.8% in 2009. Rates varied by all variables (P≤.05). For example, across all study years, prevalence was highest for females, those 35-44 years old, Caucasians and Colorado workers, but increased over time for minority groups and Wyoming employees. Prevalence was greatest for salaried workers, those with tenure of 6 to 10 years, and employees in administrative/clerical or technical support jobs. Prevalence was lowest for operators and professionals throughout all years. Similar incidence rate trends were observed.
Conclusion: The prevalence and incidence of psychiatric disorder episodes varied by subgroups and across time. Findings may inform mental health promotion programs in the oil and gas industry.
Learning Areas:
EpidemiologyOccupational health and safety
Social and behavioral sciences
Learning Objectives:
Describe the incidence and prevalence of treated psychiatric disorder episodes and their distribution by sociodemographic and work subgroups among US employees of a large oilfield services corporation.
Keyword(s): Occupational Health and Safety, Mental Health
Qualified on the content I am responsible for because: I have conducted occupational and mental health research for the past 4 years, and was the PI on this study.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.